Lexaria Bioscience Corp. - COM NEW (LEXX)

CUSIP: 52886N406

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / COM NEW
Total 13F shares
888,794
Share change
-306,795
Total reported value
$3,225,972
Price per share
$3.63
Number of holders
25
Value change
-$347,925
Number of buys
16
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 52886N406?
CUSIP 52886N406 identifies LEXX - Lexaria Bioscience Corp. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q1 2024

As of 31 Mar 2024, Lexaria Bioscience Corp. - COM NEW (LEXX) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 888,794 shares. The largest 10 holders included Invenomic Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Raymond James Financial Services Advisors, Inc., STATE STREET CORP, ADAR1 Capital Management, LLC, Welch Group, LLC, MORGAN STANLEY, NORTHERN TRUST CORP, and CITADEL ADVISORS LLC. This page lists 25 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.